Joseph Visit 2: A 52-year-old African-American male with hypertension and erectile dysfunction

Jae, a 55-year-old Korean-American male with treated hypertension presenting for routine physical
0.5 ACPE 0.5 ANCC Contract Hours 0.5 CDR 0.5 AMA PRA Category 1 Credit(s)™
Launch Date:
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

Peter H. Jones, MD, FNLA

Peter H. Jones, MD, FNLA
Associate Professor of Medicine
Section of Atherosclerosis and Lipid Research
Methodist Debakey Heart and Vascular Center
Baylor College of Medicine
Center for Cardiovascular Disease Prevention
Director, Weight Management Center
The Methodist Hospital
Houston, TX

Peter H. Jones, MD, FNLA, is an Associate Professor of Medicine and a Co-Director of the Lipid Metabolism and Atherosclerosis Clinic in the Section of Atherosclerosis and Vascular Medicine at Baylor College of Medicine in Houston, Texas. Dr. Jones is also a member of the Center for Cardiovascular Disease Prevention at the Methodist DeBakey Heart and Vascular Center in Houston. He is a specialist in the clinical management of lipid disorders and has participated in numerous clinical trials of various drugs and their effects on lipid metabolism, including all of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Dr. Jones served as Chair of the Morbidity/Mortality Review Committee for the Lipoprotein Coronary Atherosclerosis Study (LCAS); for this study, the angiographic evaluation of fluvastatin effectiveness was performed at Baylor College of Medicine. He also served as Director of the American Heart Association Lipid Disorders Training Program at Baylor College of Medicine, which involved lectures and workshops on the clinical management of dyslipidemias. Most recently, he participated in obesity drug studies, particularly involving leptin. Dr. Jones is the Medical Director of the Methodist Wellness Services at The Methodist Hospital. He sees private patients for treatment of lipid disorders and for general medical care and serves as an attending physician in general medicine at The Methodist Hospital, the Ben Taub General Hospital, and the Michael E. DeBakey Veterans Affairs Medical Center.

James A. Underberg, MD, MS, FACPM, FACP, FNLA

James Underberg, MD, MS, FACPM, FACP, FNLA
Clinical Assistant Professor of Medicine 
NYU Medical School 
Director, Primary Care Lipid Management Clinic
Bellevue Hospital Lipid Clinic
New York, New York

Dr. Underberg is a Clinical Assistant Professor of Medicine in the Division of General Internal Medicine at NYU Medical School and Director, Primary Care Lipid Management Clinic, Bellevue Hospital. He is also a member of the executive committee of the Division of General Internal Medicine. His clinical focus is Preventive Cardiovascular Medicine. He is an American Society of Hypertension Certified Specialist in Clinical Hypertension, a fellow of the American College of Preventive Medicine, a fellow of the Society for Vascular Medicine & Biology, a Diplomate of the American Board of Clinical Lipidology, and a North American Menopause Society Certified Menopause Practitioner.
Dr. Underberg is the founder and President of the New York Preventive Cardiovascular Society and a member of the Board of Directors of the Northeast Chapter of the National Lipid Association. In addition, he is on the editorial board of the Journal of Clinical Lipidology.
He graduated from Yale University with a BS and MS and from the University of Pennsylvania Medical School. His internship and residency were completed at Bellevue Hospital Medical Center. He is currently involved in several clinical trials in the areas of hypertension, lipids, diabetes and cardiovascular disease. Dr. Underberg's Clinical Practice was recently awarded recognition by the American Heart Association/American Stroke Association and the National Committee for Quality Assurance Heart-Stroke Recognition Program and the American Diabetes Association Diabetes Prevention Program. He sees patients both in his private referral practice and in the Bellevue Hospital Lipid Clinic.
1. Apply evidence-based strategies for the prevention, screening, and treatment of atherosclerosis risk factors and their comorbidities to clinical practice
2. Evaluate current and novel markers for atherosclerosis and their potential applications for CV risk detection and management, as well as their limitations
3. Optimize treatment strategies utilizing dose titration and combination therapy that may support better clinical outcomes
4. Incorporate appropriate treatment strategies for special risk populations, including minorities and women
5. Implement effective behavioral modification and counseling strategies to encourage patient compliance to therapies